Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 3 of 27
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  >   >>   >| 

Scientific Advancements
Tuesday, April 9, 2024   (0 Comments - view/add)
Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboe »
Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis...
Monday, April 8, 2024   (0 Comments - view/add)
MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S. »
MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S. De Novo Classification builds on...
Monday, April 8, 2024   (0 Comments - view/add)
Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics »
Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicato...
Friday, April 5, 2024   (0 Comments - view/add)
Florida Cancer Specialists & Research Institute Clinical Research Driving Progress to Cure Cancer »
Florida Cancer Specialists & Research Institute Clinical Research Driving Progress to Cure Cancer Clinical Trials...
Tuesday, April 2, 2024   (0 Comments - view/add)
Captiva Spine Introduces TransFasten® LSF, Lateral SI Fusion System, Creating a Comprehensive Select »
Captiva Spine Introduces TransFasten® LSF, Lateral SI Fusion System, Creating a Comprehensive Selection of ASC-Ready SI Fu...
Tuesday, April 2, 2024   (0 Comments - view/add)
Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential »
Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submissi...
Thursday, March 28, 2024   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS »
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day M...
Tuesday, March 26, 2024   (0 Comments - view/add)
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communica »
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications March 26, 2...
Tuesday, March 26, 2024   (0 Comments - view/add)
Nemours Children’s Health, Jacksonville Announces New Mental Health Program that Provides Timely Acc »
Nemours Children’s Health, Jacksonville Announces New Mental Health Program that Provides Timely Access to Treatment...
Tuesday, March 26, 2024   (0 Comments - view/add)
Zevra Therapeutics Announces Top-Line Data From The Phase 2 Clinical Trial Of KP1077 For Idiopathic »
Zevra Therapeutics Announces Top-Line Data From The Phase 2 Clinical Trial Of KP1077 For Idiopathic Hypersomnia March...
Tuesday, March 19, 2024   (0 Comments - view/add)
Debbie's Dream Foundation: Curing Stomach Cancer Announce Groundbreaking Research Fellowship Grant f »
Debbie's Dream Foundation: Curing Stomach Cancer Announce Groundbreaking Research Fellowship Grant for Gastric Cancer Rese...
Monday, March 18, 2024   (0 Comments - view/add)
ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Choleste »
ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator™ V...
Thursday, March 14, 2024   (0 Comments - view/add)
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Re »
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to i...
Thursday, March 14, 2024   (0 Comments - view/add)
SafeGuard Surgical Receives FDA "Breakthrough" Designation, Secures Funding from Tom Pepin and NFL Q »
SafeGuard Surgical Receives FDA "Breakthrough" Designation, Secures Funding from Tom Pepin and NFL QB Jameis Winston...
Thursday, March 14, 2024   (0 Comments - view/add)
Tampa General Hospital Employs New Ultrasound Therapy Designed to Treat Life-Threatening Hypertensio »
Tampa General Hospital Employs New Ultrasound Therapy Designed to Treat Life-Threatening Hypertension The hospital is...
Thursday, March 14, 2024   (0 Comments - view/add)
Positive Results from Diabetic Foot Ulcer Clinical Trial Show Dramatic Healing Rate within 12 Weeks »
Positive Results from Diabetic Foot Ulcer Clinical Trial Show Dramatic Healing Rate within 12 Weeks or Less Using Novel Om...
Thursday, March 14, 2024   (0 Comments - view/add)
Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Tr »
Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol ®  Cyclo™ for the Treatment...
Wednesday, March 13, 2024   (0 Comments - view/add)
LGM Pharma Unveils Enhanced Analytical Testing Services and Expands CDMO Portfolio with Additional S »
LGM Pharma Unveils Enhanced Analytical Testing Services and Expands CDMO Portfolio with Additional Suppository Manufacturi...
Wednesday, March 13, 2024   (0 Comments - view/add)
Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and An »
Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-...
Wednesday, March 13, 2024   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment »
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular...
Wednesday, March 13, 2024   (0 Comments - view/add)
U.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for Ensartinib »
U.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for Ensartinib March 13, 2024 12:...
Tuesday, March 12, 2024   (0 Comments - view/add)
Ibogaine By David Dardashti Announces New Algorithm to Address PTSD »
Ibogaine By David Dardashti Announces New Algorithm to Address PTSD Groundbreaking Algorithm to Help Treat Trauma Vi...
Friday, March 8, 2024   (0 Comments - view/add)
University of South Florida Tampa General Physicians Becomes First Academic Medical Group in the Nat »
University of South Florida Tampa General Physicians Becomes First Academic Medical Group in the Nation to Achieve Prestig...
Thursday, March 7, 2024   (0 Comments - view/add)
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Dise »
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024...
Thursday, March 7, 2024   (0 Comments - view/add)
SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft »
SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft March 07, 2024 09:00...
Wednesday, March 6, 2024   (0 Comments - view/add)
Memorial's Kidney Transplant Program Nationally Ranked by the Scientific Registry for Transplant Rec »
Memorial's Kidney Transplant Program Nationally Ranked by the Scientific Registry for Transplant Recipients Memorial T...
Tuesday, March 5, 2024   (0 Comments - view/add)
LiveCare Inc's (OTCMKTS: LVCE) Blood Pressure Cuff Sets New Standards in Healthcare, Fueling Remarka »
LiveCare Inc's (OTCMKTS: LVCE) Blood Pressure Cuff Sets New Standards in Healthcare, Fueling Remarkable Growth and Patient...
Tuesday, March 5, 2024   (0 Comments - view/add)
AdventHealth West Florida Division Revolutionizing Emergency Care with AirStar 1 Helicopter »
AdventHealth West Florida Division Revolutionizing Emergency Care with AirStar 1 Helicopter TAMPA, Fla. , ...
Tuesday, March 5, 2024   (0 Comments - view/add)
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion »
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion March 05, 2024 07:45 AM Eastern Standa...
Monday, March 4, 2024   (0 Comments - view/add)
Tampa General Hospital Brings New Hope for Patients with Advanced Blood Cancers »
Tampa General Hospital Brings New Hope for Patients with Advanced Blood Cancers Chimeric Antigen Receptor (CAR) T-cel...
Monday, March 4, 2024   (0 Comments - view/add)
Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Tre »
Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain...
Monday, March 4, 2024   (0 Comments - view/add)
Zevra Therapeutics Provides FDA Update On The PDUFA Action Date For Arimoclomol As A Treatment For N »
Zevra Therapeutics Provides FDA Update On The PDUFA Action Date For Arimoclomol As A Treatment For Niemann-Pick Disease Ty...
Thursday, February 29, 2024   (0 Comments - view/add)
Father of Exactech Employee Receives First Ankle Replacement Using Activit-E™ Polyethylene »
Father of Exactech Employee Receives First Ankle Replacement Using Activit-E™ Polyethylene GAINESVILLE, Fla., Feb...
Wednesday, February 28, 2024   (0 Comments - view/add)
Advancing Skin Cancer Detection: American Academy of Dermatology Journal Publishes DermaSensor's Bre »
Advancing Skin Cancer Detection: American Academy of Dermatology Journal Publishes DermaSensor's Breakthrough Melanoma Det...
Wednesday, February 28, 2024   (0 Comments - view/add)
ZyVersa Therapeutics Highlights Data from Review Article Published in Nature Reinforcing IC 100’s Ra »
ZyVersa Therapeutics Highlights Data from Review Article Published in Nature Reinforcing IC 100’s Rationale for Inhib...

Displaying page 3 of 27
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  >   >>   >| 

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)